77
17
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T79364 |
Antiangiogenic agent 4
|
Akt | Cytoskeletal Signaling; PI3K/Akt/mTOR signaling |
Antiangiogenic agent 4(Compound 3b)在HFF和HUVEC细胞中抑制Akt磷酸化,可应用于癌症研究。 | |||
T72363 |
Antiangiogenic agent 3
|
||
Antiangiogenic agent 3 是一种抗血管生成剂,具有抑制人脐静脉内皮细胞(HUVEC)生长、迁移与趋化运动的作用。此外,该化合物还能降低 Src、cdc42 以及 MAPK 的基因表达。 | |||
T62931 | Antiangiogenic agent 2 | ||
Antiangiogenic agent 2 (compound 3b) 是一种有效的胸苷磷酸化酶 (thymidine phosphorylase) 抑制剂 (IC50: 39.71 μM),表现出抗血管生成作用。 | |||
T21593 |
AAL-993
|
VEGFR | Angiogenesis; Tyrosine Kinase/Adaptors |
AAL-993 是口服有效的VEGFR 选择性抑制剂,抑制 VEGFR1、VEGFR2 和 VEGFR3 的IC50分别为 130 nM、23 nM 和 18 nM,对其他酪氨酸激酶的抑制作用较弱。AAL-993 具有抗血管生成和抗肿瘤的活性。 | |||
T6027 |
Delanzomib
德兰佐米,CEP-18770 |
Apoptosis; NF-κB; Proteasome | Apoptosis; NF-κB; Proteases/Proteasome; Ubiquitination |
Delanzomib (CEP-18770) 是一种强效的具有口服活性的蛋白酶体的胰凝乳蛋白酶样活性抑制剂,IC50为 3.8 nM。它抑制NF-κB 活性,诱导癌细胞凋亡,具有很强的抗血管生成和抗癌活性。 | |||
T8742 |
G5-7
JAK2 inhibitor G5-7 |
Apoptosis; JAK | Angiogenesis; Apoptosis; Chromatin/Epigenetic; JAK/STAT signaling; Stem Cells |
JAK2 inhibitor G5-7 (JAK2 inhibitor G5-7) 是具有口服活性的JAK2变构抑制剂,可通过结合到 JAK2,选择性的抑制JAK2介导的 EGFR 和 STAT3 的磷酸化和激活。它诱导细胞周阻滞和诱导凋亡、具有抗血管生成活性。它有用于胶质瘤研究的潜能。 | |||
T29797 |
AKB-6899
AKB6899 |
VEGFR; HIF/HIF Prolyl-Hydroxylase; HIF | Angiogenesis; Chromatin/Epigenetic; Metabolism; Tyrosine Kinase/Adaptors |
AKB-6899 是脯氨酰羟化酶结构域 3 (PHD3) 的抑制剂,可增加 GM-CSF 处理的巨噬细胞产生的 VEGF 受体的可溶形式 (sVEGFR-1)。 AKB-6899 能稳定 HIF-2α,从而诱导肿瘤相关巨噬细胞产生 sVEGFR-1 并减少肿瘤生长。 | |||
T1792L |
Regorafenib monohydrate
|
Raf; VEGFR; c-RET; PDGFR; c-Kit; Autophagy | Angiogenesis; Apoptosis; Autophagy; MAPK; Tyrosine Kinase/Adaptors |
Regorafenib monohydrate 是一种新型口服多激酶抑制剂,对VEGFR1/2/3、PDGFRβ、Kit、RET 和Raf-1的IC50分别为 13、4.2、46、22、7、1.5 和 2.5 nM。 | |||
T3289 |
Amifostine
氨磷汀,Ethyol,WR2721,Gammaphos |
Others; HIF/HIF Prolyl-Hydroxylase | Chromatin/Epigenetic; Metabolism; Others |
Amifostine (Ethyol) 是一种广谱细胞保护剂和辐射防护剂,具有清除自由基的作用。它可选择性保护正常组织免受放射线和化学疗法造成的损害。它是有效的 HIF-α1和 p53诱导剂,可降低肾脏毒性并具有抗血管生成作用。 | |||
T21334 |
Bucillamine
DE-019,Thiobutarit,Tiobutarit,布西拉明,SA96,DE 019,DE019 |
VEGFR; Antioxidant | Angiogenesis; oxidation-reduction; Tyrosine Kinase/Adaptors |
Bucillamine (DE019) 可防止高危器官移植中的缺血/再灌注损伤,抑制 VEGF 的产生。 Bucillamine 是一种具有抗风湿和抗血管生成特性的口服活性巯基供体和抗氧化剂。 Bucillamine 可用于脉络膜新生血管和类风湿性关节炎的研究。 | |||
T41003 | KG5 | Raf; FLT; PDGFR; c-Kit | Angiogenesis; MAPK; Tyrosine Kinase/Adaptors |
KG5 是 PDGFRβ 和 B-Raf 的双重变构抑制剂,对 PDGFRβ 和 PDGFRα 的 Kd 分别为 520 nM 和 300 nM。 KG5 抑制 FLT3、KIT 和 c-Raf,具有抗癌和抗血管生成活性。 | |||
T6381 |
Amifostine trihydrate
Ethyol trihydrate,WR2721,三水氨磷汀,Amifostine |
Others; HIF/HIF Prolyl-Hydroxylase | Chromatin/Epigenetic; Metabolism; Others |
Amifostine trihydrate (WR2721) 是一种广谱细胞保护剂和辐射防护剂。它可选择性保护正常组织免受放射线和化学疗法造成的损害。它是有效的HIF-α1和p53诱导剂。它通过清除氧衍生的自由基来保护细胞免受损伤。它可降低肾脏毒性并具有抗血管生成作用。 | |||
T2586 |
Cabozantinib
卡博替尼,XL184,BMS-907351 |
Apoptosis; VEGFR; FLT; c-Met/HGFR; c-RET; TAM Receptor; c-Kit | Angiogenesis; Apoptosis; Tyrosine Kinase/Adaptors |
Cabozantinib (XL184) 是一种多靶点酪氨酸激酶受体抑制剂,可以抑制 VEGFR2、c-Met、Kit、Axl 和 Flt3 (IC50=0.035/1.3/4.6/7/11.3 nM)。Cabozantinib 具有抗肿瘤和抗血管生成活性。 | |||
T1792 |
Regorafenib
BAY 73-4506,瑞戈非尼,Fluoro-Sorafenib,瑞格非尼 |
Raf; VEGFR; c-RET; PDGFR; c-Kit; Autophagy | Angiogenesis; Apoptosis; Autophagy; MAPK; Tyrosine Kinase/Adaptors |
Regorafenib (BAY 73-4506) 是一种多靶点受体酪氨酸激酶抑制剂,抑制 RET、C-RAF、VEGFR2、c-Kit、VEGFR1 和 PDGFRβ (IC50=1.5/2.5/4.2/7/13/22 nM),具有口服活性。Regorafenib 具有抗肿瘤和抗血管生成活性。 | |||
T5164 |
Cabozantinib hydrochloride
XL184,Cabozantinib hydrochloride (849217-68-1(free base)),BMS-907351,盐酸卡博替尼 |
VEGFR; FLT; c-Met/HGFR; TAM Receptor; c-Kit; ROR | Angiogenesis; Metabolism; Tyrosine Kinase/Adaptors |
Cabozantinib hydrochloride (XL184) 是一种有效的泛酪氨酸激酶抑制剂,可抑制 VEGFR2、c-Met、Kit、Axl 和 Flt4(IC50:0.035、1.3、4.6、7 和 6 nM)。 | |||
T21746 |
Terameprocol
tetramethyl Nordihydroguaiaretic Acid,EM-1421 |
HIV Protease | Microbiology/Virology; Proteases/Proteasome |
Terameprocol (EM-1421) 是 Nordihydroguaiaretic acid 的合成衍生物,是非选择性脂氧合酶抑制剂。 | |||
T73368 |
UniPR505
|
Ephrin Receptor | Tyrosine Kinase/Adaptors |
UniPR505 是一种有效的 EphA2 拮抗剂(IC50:0.95 µM),是一种具有抗血管生成作用的新型 3α-氨基甲酰氧基衍生物。 | |||
T16545 |
Pivanex
Pivalyloxymethyl butyrate,AN-9 |
Apoptosis; HDAC; Bcr-Abl | Angiogenesis; Apoptosis; Chromatin/Epigenetic; Cytoskeletal Signaling; DNA Damage/DNA Repair; Tyrosine Kinase/Adaptors |
Pivanex (Pivalyloxymethyl butyrate) 是丁酸的一种衍生物,是具有口服活性的 HDAC 抑制剂。Pivanex 通过下调 bcr-abl 蛋白增强凋亡。Pivanex 显示出抗转移和抗血管生成的活性。 | |||
T2644 |
(E)-Daporinad
Daporinad,(E)-N-[4-(1-BENZOYL-PIPERIDIN-4-YL)-BUTYL]-3-PYRIDIN-3-YL-ACRYLAMIDE,APO866,FK866,达珀利奈 |
NAMPT; Transferase; Autophagy | Autophagy; Metabolism |
(E)-Daporinad (FK866) 是一种烟酰胺磷酸核糖基转移酶的小分子抑制剂,具有潜在的抗肿瘤和抗血管生成活性,IC50为 0.09 nM。 | |||
T1996 |
Defactinib
PF-04554878,VS-6063 |
FAK | Angiogenesis; Cytoskeletal Signaling; Tyrosine Kinase/Adaptors |
Defactinib (VS-6063) 是新型的 FAK 抑制剂,能够时间和剂量依赖性的抑制 FAK 在 Tyr397 位点磷酸化。 | |||
T19668 |
Tiomolibdate diammonium
Ammonium molybdenum sulfide,Ammonium tetrathiomolybdate,NSC 286644,ATTM,四硫钼酸铵,Coprexa |
Others | Others |
Tiomolibdate diammonium (NSC-286644) 是超氧化物歧化酶 1 (SOD1) 的抑制剂,具有抗血管生成和抗肿瘤活性。 Tiomolibdate diammonium 抑制铜酶的活性,包括 SOD1 和 COX。 | |||
T2577 |
Dienogest
地诺孕素,STS 557 |
Apoptosis; Estrogen/progestogen Receptor; Progesterone Receptor; Autophagy | Apoptosis; Autophagy; Endocrinology/Hormones; Others |
Dienogest (STS 557) 是一种孕酮受体激动剂,作用于子宫内膜异位,有口服的子宫内膜活性。 | |||
T2456 |
Tivozanib
替沃扎尼,AV-951,KRN951 |
VEGFR; PDGFR; Ephrin Receptor | Angiogenesis; Tyrosine Kinase/Adaptors |
Tivozanib (KRN951) 是一种选择性的 VEGFR 1/2/3抑制剂,它们的 IC50值分别为0.21 nM、0.16 nM、0.24 nM。 | |||
T6091 |
CP-673451
|
VEGFR; PDGFR; c-Kit | Angiogenesis; Tyrosine Kinase/Adaptors |
CP673451 是选择性的血小板源生长因子受体 (PDGFR) 抑制剂,能够抑制 PDGFRα (IC50:10 nM) 和 PDGFRβ (IC50:1 nM) 的活性。 | |||
T16380 |
OGT 2115
|
Others | Others |
OGT 2115是一种肝素酶(IC50 = 0.4µM)抑制剂,肝素酶是一种将硫酸肝素分解成葡萄糖醛酸(GlcUA)和 n -乙酰氨基葡萄糖(GlcNAc)的酶。同时,OGT 2115也具有抗血管生成性能(IC50=1 μM)。 | |||
T13178 |
Toceranib
托西尼布,PHA 291639E,SU11654 |
VEGFR; PDGFR; c-Kit | Angiogenesis; Tyrosine Kinase/Adaptors |
Toceranib (PHA 291639E) 是口服具有活力的受体酪氨酸激酶 (RTK) 抑制剂,能有效抑制PDGFR,VEGFR,Kit,抑制 PDGFRβ 和 Flk-1/KDR 的Ki 分别为 5 nM 和 6 nM。它具有抗肿瘤和抗血管生成作用,用于研究犬肥大细胞肿瘤。 | |||
T1178 |
Temozolomide
NSC 362856,替莫唑胺,TZM,CCRG 81045,TMZ |
Apoptosis; DNA Alkylator/Crosslinker; DNA/RNA Synthesis; Autophagy | Apoptosis; Autophagy; Cell Cycle/Checkpoint; DNA Damage/DNA Repair |
Temozolomide (TMZ) 是一种 DNA 烷基化剂,具有血脑屏障渗透性和口服活性。Temozolomide 具有抗肿瘤活性和抗血管生成活性,还可以诱导细胞凋亡和自噬。 | |||
T76941 |
Carotuximab
DE-122,TRC105 |
TGF-beta/Smad; Immunology/Inflammation related | Immunology/Inflammation; Stem Cells |
Carotuximab(DE-122)是一种新型内胆苷抗体,具有强大的抗血管生成活性和抗炎活性。Carotuximab 可阻断内皮糖蛋白 (CD105) 及其下游 Smad 信号通路。Carotuximab 具有免疫调节和抗肿瘤作用,可预防高胆固醇血症和高血糖诱导的人内皮功能障碍。 | |||
T1608 |
ADH-1 trifluoroacetate
Exherin trifluoroacetate |
Dehydrogenase | Metabolism |
ADH-1 trifluoroacetate (Exherin trifluoroacetate) 是一种选择性的、竞争性N-钙粘蛋白拮抗剂,具有潜在抗肿瘤和抗血管生成作用。 | |||
T15616 |
JNJ-10198409
3-氟-N-(6,7-二甲氧基-2,4-二氢茚并[1,2-C〕吡唑-3-基苯基胺,JNJ-10198409 |
PDGFR | Angiogenesis; Tyrosine Kinase/Adaptors |
JNJ-10198409 是相对选择性的、ATP 竞争性的、具有口服活性的血小板衍生生长因子受体酪氨酸激酶抑制剂,其IC50=2 nM。它对PDGFR-β激酶 (IC50=4.2 nM) 和PDGFR-α激酶 (IC50=45 nM) 有较好的抑制作用。它是双重机制的抗血管生成和肿瘤细胞的抗增殖剂。 | |||
T10883L |
CRA-026440 hydrochloride
CRA-026440 hydrochloride(847460-34-8 Free base) |
HDAC | Chromatin/Epigenetic; DNA Damage/DNA Repair |
CRA-026440 hydrochloride 是有效的、广谱的 HDAC 抑制剂。CRA-026440 hydrochloride 作用于 HDAC1,HDAC2,HDAC3,HDAC6,HDAC8 和 HDAC10, Ki 值分别为 4 nM,14 nM,11 nM,15 nM,7 nM 和 20 nM。CRA-026440 hydrochloride 具有抗血管生成和抗肿瘤活性。 | |||
T15181 |
DuP-697
|
COX | Immunology/Inflammation; Neuroscience |
DuP-697 是一种不可逆的特异性 COX-2 抑制剂,对人 COX-2 和 COX-1 的 IC50 值为 10 nM 和 800 nM。 DuP-697 具有抗增殖活性,IC50 为 42.8 nM。 DuP-697 具有抗血管生成、抗炎、解热和凋亡作用。 | |||
T6695 |
Tasquinimod
他喹莫德,ABR-215050 |
HDAC | Chromatin/Epigenetic; DNA Damage/DNA Repair |
Tasquinimod (ABR-215050) 是一种口服抗血管生成剂,有潜在的抗肿瘤活性。它也是 S100A9抑制剂,与 HDAC4Zn2+结合结构域结合的 Kd 值在10到30 nM 之间。 | |||
T14871 |
Carboxyamidotriazole Orotate
L-651582 Orotate,CAI Orotate |
Calcium Channel | Membrane transporter/Ion channel; Metabolism |
Carboxyamidotriazole Orotate (L-651582 Orotate) 是一种可口服的信号转导抑制剂,是Carboxyamidotriazole (CAI) 的乳清酸盐形式。它是一种非电压性钙通道和钙通道介导的信号通路的细胞抑制剂,具有抗癌、抗炎活性和抗血管生成作用。 | |||
T22443 |
Triglycidyl isocyanurate
Tris(2,3-epoxypropyl) Isocyanurate,Teroxirone,TGIC,1,3,5-三缩水甘油-S-三嗪三酮,TGI |
Apoptosis | Apoptosis |
Triglycidyl isocyanurate (Teroxirone) 是一种三氮烯三环氧化合物,可通过 p53的激活抑制非小细胞肺癌细胞的生长。它诱导细胞凋亡,具有抗血管生成和抗肿瘤活性,用于癌症研究。 | |||
T26047 |
Razoxane, (R)-
ICRF-186,ICRF186,NSC-169779,ICRF 186,NSC 169779 |
||
Razoxane, (R)- shows antiangiogenic effects. | |||
T70724 |
GSK-2256098 HCl
|
||
GSK-2256098 HCl is a focal adhesion kinase-1 (FAK) inhibitor with potential antiangiogenic and antineoplastic activities. | |||
T71208 |
GO-Y078
|
||
GO-Y078 is an antiangiogenic curcumin analog which inhibits actin stress fiber formation, thereby resulting in mobility inhibition. | |||
T25290 |
DAT1
DAT-1,DAT 1 |
||
DAT1 is an antimitotic and antiangiogenic that acts by binding to the colchicine binding site of tubulin. | |||
T2358L |
ENMD-2076 tartrate
ENMD-2076,L-(+) Tartrate salt of ENMD-981693,ENMD2076,ENMD 2076 |
||
ENMD-2076 is an orally active kinase inhibitor. It also has antiangiogenic and antiproliferative mechanisms of action. | |||
T70609 |
Bisnafide mesylate
|
||
Bisnafide is a Naphthalimide Analogue that acts as DNA intercalator and topo II inhibitor. It is also an antiangiogenic agent. Antiangiogenic agents can normalize tumor vessels and promote the delivery of cytotoxic agents to tumor sites. | |||
T28348 |
PD 404182
PD404182,PD-404182 |
||
PD-404182, an inhibitor of KDO 8-P synthase (Ki = 26 nM), is a otential antibiotic of gram negative bacteria. PD-404182 also exhibits antiviral and antiangiogenic activity in vitro. | |||
T37377 | Aminohexylgeldanamycin | ||
Aminohexylgeldanamycin (AHGDM), a derivative of Geldanamycin, is a highly effective inhibitor of HSP90. It exhibits considerable antiangiogenic and antitumor properties[1]. | |||
T38522 |
Aminohexylgeldanamycin hydrochloride
AHGDM hydrochloride,Aminohexylgeldanamycin hydrochloride |
||
Aminohexylgeldanamycin (AHGDM) hydrochloride is a Geldanamycin derivative and a powerful inhibitor of HSP90. It exhibits significant antiangiogenic and antitumor properties. | |||
T14872 |
Carboxyamidotriazole
CAI,L-651582 |
Calcium Channel | Membrane transporter/Ion channel; Metabolism |
Carboxyamidotriazole is a cytostatic inhibitor of non-voltage-operated calcium channels and calcium channel-mediated signaling pathways. It shows anti-inflammatory, anti-tumor, and antiangiogenic effects. | |||
T71488 | Cremastranone | ||
Cremastranone is a natural antiangiogenic homoisoflavanone. Cremastranone inhibits the proliferation, migration, and tube formation ability of human retinal microvascular endothelial cells. | |||
T15234 |
ENMD-1198
IRC 110160,ENMD-119,ENMD 1198 |
HIF; STAT | Angiogenesis; Chromatin/Epigenetic; JAK/STAT signaling; Stem Cells |
ENMD-119 is a 2-methoxyestradiol analog with antiproliferative and antiangiogenic activity. It is suitable for inhibiting HIF-1α and STAT3 in human HCC cells. | |||
T24657 |
YLT192
YLT 192,YLT-192 |
||
YLT192 is an orally active and bioavailable VEGFR2 inhibitor. It also has potent antiangiogenic activity and antitumor efficacy. | |||
TP1879 |
HSDVHK-NH2
P11 |
||
Potent antagonist of the integrin αvβ3-vitronectin interaction (IC50 = 25.72 nM). Blocks proliferation and induces apoptosis in HUVECs; antiangiogenic. | |||
T11930 | M8891 | Others | Others |
M8891 is an orally active, reversible and brain penetrant Methionine Aminopeptidase-2 (MetAP-2) inhibitor(IC50 :54nM;Ki:4.33 nM).M8891 inhibits growth of primary endothelial cells as well as tumor cells and demonstrates antiangiogenic and antitumoral acti |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TN1112 |
Morellic acid
|
Others | Others |
Morellic acid 提取于 Garcinia Morella 中,具有抗血管生成作用。 | |||
T3776 |
Rhapontigenin
丹叶大黄素,Protigenin |
P450; Antibacterial; Antifungal | Metabolism; Microbiology/Virology |
Rhapontigenin (Protigenin) 是一种基于机制的选择性细胞色素 P450 1A1 (IC50: 400 nM) 灭活剂。它是一种芳烃羟化酶,可激活作为致癌物质的多环芳烃。它是白藜芦醇的天然类似物,具有抗癌,抗氧化剂,抗真菌和抗菌活性。 | |||
T1335 |
Mycophenolic acid
霉酚酸,Mycophenolate,RS-61443 |
Apoptosis; Dehydrogenase; Endogenous Metabolite; Antibacterial; Antibiotic; UGT; Antifungal | Apoptosis; Metabolism; Microbiology/Virology |
Mycophenolic acid (Mycophenolate) 是一种有效的非竞争性肌苷单磷酸脱氢酶 (IMPDH) 抑制剂,EC50为 0.24 µM。它对多种 RNA 病毒具有抗病毒作用。它也是一种免疫抑制剂,具有抗血管生成和抗肿瘤作用。 | |||
T1011 |
Itraconazole
伊曲康唑,R51211 |
P450; Hedgehog/Smoothened; Antibiotic; Autophagy; Antifungal | Autophagy; GPCR/G Protein; Metabolism; Microbiology/Virology; Stem Cells |
Itraconazole (R51211) 是三唑类抗真菌药,也是口服活性的Hedgehog 信号通路拮抗剂,IC50约为 800 nM。它也是 oxysterol-binding protein 抑制剂。它抑制羊毛甾醇 14α-脱甲基酶,从而抑制羊毛甾醇向麦角固醇的氧化转化。它有抗癌和抗血管作用。 | |||
T3S2027 |
Rubusoside
|
Others | Others |
Rubusoside 是天然的增溶剂及甜味剂,具有良好的抗血管新生和抗过敏药的特性。 | |||
T3878 |
Raddeanin A
NSC382873,竹节香附素A,Anemodeanin A,Raddeanin R3 |
Apoptosis; HDAC | Apoptosis; Chromatin/Epigenetic; DNA Damage/DNA Repair |
Raddeanin A (NSC-382873) 是竹节香附中的一种天然三萜皂苷,可抑制组蛋白去乙酰化酶,具有很强的抗血管生成能力和抗肿瘤活性。 | |||
T4S0999 |
(2S)-Isoxanthohumol
Isoxanthohumol,(2S)-异黄腐酚,异黄腐醇 |
Virus Protease; HSV | Microbiology/Virology |
(2S)-Isoxanthohumol 是一种由啤酒花原异戊烯基二氢黄酮 Isoxanthohumol 的微生物转化代谢物。 | |||
T3864 |
Erianin
|
BCL; Antibacterial | Apoptosis; Microbiology/Virology |
Erianin 能抑制吲哚胺-2,3-双加氧酶诱导的肿瘤血管生成,可用作退烧药和止疼剂。 | |||
T7032 |
Eupatorin
|
Others; P450 | Metabolism; Others |
Eupatorin 是天然存在的黄酮,可捕获 G2-M 细胞周期,激活多个 caspase、细胞色素 C 的释放、多聚 (ADP-核糖) 聚合酶的裂解,促使凋亡细胞死亡。 | |||
T2S0886 |
Terrestrosin D
|
Apoptosis; Others | Apoptosis; Others |
Terrestrosin D 是从刺蒺藜中提取得到一种的甾体皂苷,可诱导细胞周期阻滞和癌细胞凋亡,具有抗血管生成的活性。 | |||
TN1236 |
3',4',7-Trihydroxyisoflavone
|
MAPK; JNK | MAPK |
3',4',7-Trihydroxyisoflavone 是大豆异黄酮大豆苷元衍生物,是 Cot (Tpl2/MAP3K8) 和 MKK4 抑制剂,具有抗癌、抗血管生成和自由基清除特性。3',4',7-Trihydroxyisoflavone 通过调节小鼠胆碱能功能和BDNF信号通路增强记忆作用,可改善因内源性或外源性糖皮质激素而受损的皮肤屏障功能,可用于研究特应性皮炎。 | |||
T5S2343 |
Acetylshikonin
乙酰紫草素,Acetyl shikonin |
Others; P450; AChE | Metabolism; Neuroscience; Others |
Acetylshikonin 来源于紫草根,具有抗癌、抗炎作用。它是一种 AChE 抑制剂,具有很强的抗凋亡活性。它是一种非选择性的细胞色素 P450抑制剂,对所有 P450 亚型抑制的 IC50值范围为 1.4-4.0 μM。 | |||
TN2892 | 3,5,7-Trihydroxychromone | Others | Others |
3,5,7-Trihydroxychromone exhibits weak antiangiogenic activity. | |||
T40942 |
(R)-(4′-Hydroxy)-5,7-dihydroxy-4-chromanone
|
||
(R)-(4′-Hydroxy)-5,7-dihydroxy-4-chromanone, an antiangiogenic homoisoflavonoid, exhibits activity against human retinal microvascular endothelial cells. | |||
TMA1743 |
Ergosterol peroxide
|
ERK; VEGFR; p38 MAPK; Wnt/beta-catenin; Akt; JAK; CDK; JNK; STAT; Antifection | Angiogenesis; Cell Cycle/Checkpoint; Chromatin/Epigenetic; Cytoskeletal Signaling; JAK/STAT signaling; MAPK; Microbiology/Virology; PI3K/Akt/mTOR signaling; Stem Cells; Tyrosine Kinase/Adaptors |
Ergosterol peroxide is an inhibitor of osteoclast differentiation, which has antiviral, trypanocidal, antitumor, and antiangiogenic actions, it can stimulate Foxo3a activity by inhibiting pAKT and c-Myc and activating pro-apoptotic protein Puma and Bax to | |||
TN2553 |
1-Methyl-2-undecyl-4(1H)-quinolone
1-Methyl-2-undecylquinolin-4(1H)-one |
MAO | Metabolism; Neuroscience |
1-Methyl-2-undecyl-4(1H)-quinolone, and dihydroevocarpine should also be served as the chemical markers together with evodiamine for the quality control of Evodia rutaecarpa (Juss.) Benth. 1-Methyl-2-undecyl-4(1H)-quinolone shows a selective inhibition of type B MAO (MAO-B) activity with the IC(50) value of 15.3 microM using a substrate kynuramine, but does not inhibit type A MAO (MAO-A) activity.It can mitigate high phosphate-induced human aortic valve interstitial cells (HAVICs) calcification ... | |||
T36749 |
Herboxidiene
|
||
Herboxidiene is a polyketide originally isolated from S. chromofuscus that has diverse biological activities.[1],[2,][3],[4],[5] It inhibits growth of HeLa S3, SK-MEL-2, PC3, A549, and EBC-1 cells with GI50 values ranging from 7.4 to 62 nM.3 Herboxidiene is cytostatic against human umbilical vein endothelial cells (HUVECs; (IC50 = 26 nM)) and inhibits VEGF-induced invasion and tube formation of serum-starved HUVECs in a concentration-dependent manner, indicating antiangiogenic activity.[4] Herbo... |